Clinical trials

7

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

OPN Balloon for SAFE Recanalization of Calcified Coronary Lesions

The goal of the OPEN-SAFE registry is to describe the contemporary use and outcomes of SIS-OPN in North America.

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Minneapolis Heart Institute FoundationUpdated: Jun 12, 2026Duration: 1 Week
Eligibility criteria

Age 18 years or older [+2]

Subjects who have opted out of being included in research related data collectio...

Status: Recruiting

Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

This is a multi-center, prospective, observational study designed to evaluate the impact of LV myocardial fibrosis extent assessed by CMR on LV reverse remodeling and clinical outcomes post TEER. The target sample will be up to 125 patients enrolled to achieve 100 evaluable at 6 months of follow-up. Enrollment will occur at up to eight centers.

Participants needed: 125
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Minneapolis Heart Institute FoundationUpdated: Dec 23, 2025Locations: 6
Eligibility criteria

Concomitant PCI and TEER [+8]

Status: Recruiting

DESIFOR-EXPAND (MHIF)

The DESIFOR pilot study was conducted to determine the feasibility of utilizing an n-of-1 trial to facilitate tolerance of unblinded rosuvastatin in patients with prior statin intolerance

Participants needed: 100
Trial details
Phase: Phase 4Age: 21+Biological sex: AllType: InterventionalSponsor: Minneapolis Heart Institute FoundationUpdated: Feb 3, 2025Locations: 1
Eligibility criteria

Adult patients (≥ 21 years old) with a prior history of statin intolerance. Stat... [+1]

Women who are pregnant, nursing or attempting to become pregnant [+2]

Status: Recruiting

Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)

This is a phase IV, prospective, open label, randomized-controlled study that will compare radial access with state-of-the-art femoral access in patients without ST-segment elevation acute myocardial infarction undergoing cardiac catheterization. Subjects will be randomized 1:1 into 2 treatment groups: radial access and state-of-the-art femoral access. Randomization will be performed in blocks of 50 per site. Similarly, a second sub-randomization will be performed in the femoral access group into use of 18 vs 21 gauge needles, also in a 1:1 fashion.

Participants needed: 3,266
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Minneapolis Heart Institute FoundationUpdated: Jan 24, 2025Locations: 6
Eligibility criteria

Age 18 years and older [+3]

Primary PCI for STEMI [+11]

Status: Recruiting

Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

The purpose of the research is to determine whether a class of medication called SGLT2 inhibitor will improve the heart's function and reduce its enlargement after a heart attack. Participation in this study will involve taking this class of medication (or a placebo) once daily for six months, one cardiac magnetic resonance imaging (MRI) test during your initial hospitalization, follow-up phone calls at 1 and 3 months, and one cardiac MRI and clinic visit at six months. This is a single center study.

Participants needed: 81
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Minneapolis Heart Institute FoundationUpdated: Oct 8, 2024Locations: 1
Eligibility criteria

Patients with their first STEMI (>18 years) who underwent successful primary PCI... [+3]

Contraindication to cardiac MRI [+12]

Status: Recruiting

Progress Bifurcation Global Registry

Coronary bifurcation lesions are lesions (or blockages) that occur at or near the intersection of a major coronary artery and one of the arteries' side branches. Numerous techniques and devices have been developed to treat coronary bifurcations; however, these types of lesions remain some of the most challenging, both in terms of procedural success and outcome. This study is designed as an observational, multi-center registry that will collect information on treatment strategies and outcomes of consecutive patients undergoing percutaneous coronary interventions (PCI) in coronary bifurcations among various participating centers, in order to determine the frequency of bifurcation PCI, the procedural strategies utilized, and the procedural outcomes.

Participants needed: 4,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Minneapolis Heart Institute FoundationUpdated: Oct 29, 2021Locations: 1
Eligibility criteria

Over 18 years of age [+1]

Status: Recruiting

Progress Complication

Coronary angiography and percutaneous coronary intervention (PCI) is often performed in patients with ischemic heart disease. The safety of PCI has improved with new devices and strategies, but complications still occur, especially during complex procedures. The objectives of this multi-center observational registry are to examine frequency of complications occuring during cardiac catheterization and PCI, examine procedural strategies utilized for complication management, and evaluate the clinical outcomes (both immediate and during follow-up.)

Participants needed: 4,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Minneapolis Heart Institute FoundationUpdated: Oct 29, 2021Locations: 1
Eligibility criteria

Over 18 years of age [+2]